1037 related articles for article (PubMed ID: 8392873)
21. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
[TBL] [Abstract][Full Text] [Related]
22. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
Siegbahn A; Ruusuvaara L
Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
[TBL] [Abstract][Full Text] [Related]
23. Hemostatic effects of smoking and oral contraceptive use.
Fruzzetti F
Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S369-74. PubMed ID: 10368523
[TBL] [Abstract][Full Text] [Related]
24. Comparative studies of 30 micrograms ethinyl estradiol combined with gestodene and desogestrel on blood coagulation, fibrinolysis, and platelets.
Daly L; Bonnar J
Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):430-7. PubMed ID: 2142580
[TBL] [Abstract][Full Text] [Related]
25. Multicenter trial of two monophasic oral contraceptives containing 30 mcg ethinylestradiol and either desogestrel or gestodene in Thai women.
Koetsawang S; Charoenvisal C; Banharnsupawat L; Singhakovin S; Kaewsuk O; Punnahitanont S
Contraception; 1995 Apr; 51(4):225-9. PubMed ID: 7796587
[TBL] [Abstract][Full Text] [Related]
26. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
Scarabin PY; Plu-Bureau G; Zitoun D; Bara L; Guize L; Samama MM
Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323
[TBL] [Abstract][Full Text] [Related]
27. The effects on hemostasis of oral contraceptives containing desogestrel.
Stubblefield PG
Am J Obstet Gynecol; 1993 Mar; 168(3 Pt 2):1047-52. PubMed ID: 8447359
[TBL] [Abstract][Full Text] [Related]
28. Effect of two oral contraceptives containing ethinylestradiol and gestodene or norgestimate upon androgen parameters and serum binding proteins.
Wiegratz I; Jung-Hoffmann C; Kuhl H
Contraception; 1995 Jun; 51(6):341-6. PubMed ID: 7554973
[TBL] [Abstract][Full Text] [Related]
29. Decreased plasma tissue factor pathway inhibitor in women taking combined oral contraceptives.
Harris GM; Stendt CL; Vollenhoven BJ; Gan TE; Tipping PG
Am J Hematol; 1999 Mar; 60(3):175-80. PubMed ID: 10072106
[TBL] [Abstract][Full Text] [Related]
30. The effects of low-dose oral contraceptives on coagulation and fibrinolysis in two high-risk populations: young female smokers and older premenopausal women.
Notelovitz M; Levenson I; McKenzie L; Lane D; Kitchens CS
Am J Obstet Gynecol; 1985 Aug; 152(8):995-1000. PubMed ID: 4025463
[TBL] [Abstract][Full Text] [Related]
31. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.
Oelkers W; Foidart JM; Dombrovicz N; Welter A; Heithecker R
J Clin Endocrinol Metab; 1995 Jun; 80(6):1816-21. PubMed ID: 7775629
[TBL] [Abstract][Full Text] [Related]
32. Effects of three types of combined O.C. pills on blood coagulation, fibrinolysis and platelet function.
Prasad RN; Koh S; Ratnam SS
Contraception; 1989 Apr; 39(4):369-83. PubMed ID: 2524360
[TBL] [Abstract][Full Text] [Related]
33. Effects of two oral contraceptives, containing 30 or 20 microg of ethinyl estradiol in combination with gestodene, on blood coagulation and fibrinolysis in Brazilian women.
Ferreira AC; Montes MB; Franceschini SA; Toloi MR
Int J Fertil Womens Med; 2001; 46(5):265-70. PubMed ID: 11720199
[TBL] [Abstract][Full Text] [Related]
34. Coagulation and anticoagulation effects of contraceptive steroids.
Samsioe G
Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1523-7. PubMed ID: 8178901
[TBL] [Abstract][Full Text] [Related]
35. A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins.
Crook D; Godsland IF; Worthington M; Felton CV; Proudler AJ; Stevenson JC
Am J Obstet Gynecol; 1993 Nov; 169(5):1183-9. PubMed ID: 8238183
[TBL] [Abstract][Full Text] [Related]
36. Enhanced generation and resolution of fibrin in women above the age of 30 years using oral contraceptives low in estrogen.
Gram J; Munkvad S; Jespersen J
Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):438-42. PubMed ID: 2372037
[TBL] [Abstract][Full Text] [Related]
37. Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial.
Scarabin PY; Alhenc-Gelas M; Plu-Bureau G; Taisne P; Agher R; Aiach M
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3071-8. PubMed ID: 9409295
[TBL] [Abstract][Full Text] [Related]
38. Effect on blood coagulation and fibrinolysis in women using norethisterone or a combination of ethinyloestradiol and quingestianol.
Korsan-Bengtsen K; Larsson B
Gynecol Obstet Invest; 1978; 9(6):312-8. PubMed ID: 754993
[TBL] [Abstract][Full Text] [Related]
39. Effect of two low-dose gestodene containing monophasic oral contraceptives on hemostasis in Bulgarian women.
Uchikova E; Pehlivanov B
Expert Opin Pharmacother; 2008 Aug; 9(11):1839-44. PubMed ID: 18627323
[TBL] [Abstract][Full Text] [Related]
40. Effects of oral contraceptives containing 50 microgram estrogen on blood coagulation in non-Caucasian women.
Tsakok FH; Koh S; Ratnam SS
Contraception; 1980 May; 21(5):505-27. PubMed ID: 7428360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
